1. Home
  2. ADVM vs FAT Comparison

ADVM vs FAT Comparison

Compare ADVM & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • FAT
  • Stock Information
  • Founded
  • ADVM 2006
  • FAT 2017
  • Country
  • ADVM United States
  • FAT United States
  • Employees
  • ADVM N/A
  • FAT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • FAT Restaurants
  • Sector
  • ADVM Health Care
  • FAT Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • FAT Nasdaq
  • Market Cap
  • ADVM 59.5M
  • FAT 49.8M
  • IPO Year
  • ADVM 2014
  • FAT 2017
  • Fundamental
  • Price
  • ADVM $2.41
  • FAT $2.18
  • Analyst Decision
  • ADVM Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • ADVM 5
  • FAT 1
  • Target Price
  • ADVM $26.40
  • FAT $10.00
  • AVG Volume (30 Days)
  • ADVM 430.7K
  • FAT 45.2K
  • Earning Date
  • ADVM 05-14-2025
  • FAT 05-08-2025
  • Dividend Yield
  • ADVM N/A
  • FAT 12.79%
  • EPS Growth
  • ADVM N/A
  • FAT N/A
  • EPS
  • ADVM N/A
  • FAT N/A
  • Revenue
  • ADVM $1,000,000.00
  • FAT $582,704,000.00
  • Revenue This Year
  • ADVM N/A
  • FAT $2.29
  • Revenue Next Year
  • ADVM $42.58
  • FAT $5.81
  • P/E Ratio
  • ADVM N/A
  • FAT N/A
  • Revenue Growth
  • ADVM N/A
  • FAT 10.63
  • 52 Week Low
  • ADVM $1.78
  • FAT $2.11
  • 52 Week High
  • ADVM $10.14
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 40.10
  • FAT 33.71
  • Support Level
  • ADVM $2.15
  • FAT $2.20
  • Resistance Level
  • ADVM $2.33
  • FAT $2.55
  • Average True Range (ATR)
  • ADVM 0.23
  • FAT 0.19
  • MACD
  • ADVM 0.04
  • FAT -0.04
  • Stochastic Oscillator
  • ADVM 52.58
  • FAT 0.00

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: